DKK1 and chronic kidney disease: This ongoing skeletal remodeling imbalance may be further mediated by wingless/integrated (Wnt) pathway inhibitors such as sclerostin and Dickkopf-1 (DKK1), which are upregulated in CKD and contribute to both bone fragility and vascular calcification (47).